ALGSNasdaq

Aligos Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1799448

Develops therapeutics for liver diseases and viral infections like HBV, MASH, obesity, and coronaviruses

red 8-K · 90d

$33M

Market cap

$5.77

Last close

+6.3%

+2.1%

104K

Volume

Price · last 40 sessions-10.4%

May 4L $4.91 · H $6.69Jun 30

113

Total filings

Jun 26, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance